Finally a trial that completes the cohort and they all stay on. This should mean recruitment is smoother and as it is palatable then will mean acceptance and administering of the drug should be a non issue. This is also a good start for furthering the other human trials like the Covid trial which is mentioned. Just need some blood analysis that says reduced markers in patients.
Now lets see if anyone in the market is paying attention at all??
Ann: MND Trial Successfully Completes First Patient Cohort, page-7
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
-0.015(7.50%) |
Mkt cap ! $90.96M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 18.5¢ | $106.2K | 550.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 714303 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 26750 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |